How to build population level evidence for events that haven't happened

Airfinity welcomes some of the leading experts across the life science space to a live industry roundtable, where they discussed pre-emptive health economics, the role of forecasting in improving disease outcomes and the strategies needed to reduce disease burden. Speakers include: → Sasha Siegel, PhD, VP of Disease Outcomes at Airfinity → Matt Linley, PhD, Senior Director, Analytics and Forecasting at Airfinity → Sir Peter Donnelly, CEO and Founder of Genomics Plc and Emeritus Professor of Statistical Science at the University of Oxford → Prof. Lotte Steuten, PhD, Deputy Chief Executive of the Office of Health Economics (OHE) → Jean-Bernard Gruenberger, Director for Value & Access, Novartis Global Health